Ongentys (Opicapone)

Opicapone, the active ingredient in Ongentys, is a catechol‑O‑methyltransferase (COMT) inhibitor presented as a tablet for oral use. It is used as an adjunct therapy to manage motor fluctuations in adults with Parkinson's disease. GNH USA supplies Ongentys as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ongentys as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ongentys is a COMT inhibitor indicated for use in the Parkinson's disease treatment pathway, specifically to reduce motor fluctuations.

- Parkinson's disease: Improves "on" time without troublesome dyskinesia. - Adjunct therapy: Enhances the effect of levodopa/carbidopa regimens. - Motor fluctuation management: Reduces the frequency of "off" periods experienced by patients.

The most  … … ");